Skip to content
10-Q

Quarterly Report

BIOLARGO, INC. BLGO

0001437749-25-035239

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 313.76M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$6.71M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$1.29M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $4.55M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $3.55M
Stockholders Equity Q3 2025 · Sep 30, 2025 $6.58M
Stockholders Equity Q3 2025 · Dec 31, 2024 $8.85M
Current Liabilities Q3 2025 · Sep 30, 2025 $3.45M
Current Liabilities Q3 2025 · Dec 31, 2024 $2.65M
Total Liabilities Q3 2025 · Sep 30, 2025 $5.92M
Total Liabilities Q3 2025 · Dec 31, 2024 $4.46M
Current Assets Q3 2025 · Sep 30, 2025 $5.78M
Current Assets Q3 2025 · Dec 31, 2024 $7.14M
Total Assets Q3 2025 · Sep 30, 2025 $9.13M
Total Assets Q3 2025 · Dec 31, 2024 $10.51M
Eps Basic Q3 2025 · Sep 30, 2025 −$0.02
Eps Basic Q3 2025 · Sep 30, 2025 −$0.03
Eps Basic Q3 2025 · Sep 30, 2024 −$0.00
Eps Basic Q3 2025 · Sep 30, 2024 −$0.01
Sga Expense Q3 2025 · Sep 30, 2025 $3.09M
Sga Expense Q3 2025 · Sep 30, 2025 $8.34M
Sga Expense Q3 2025 · Sep 30, 2024 $2.09M
Sga Expense Q3 2025 · Sep 30, 2024 $6.72M
Rd Expense Q3 2025 · Sep 30, 2025 $615K
Rd Expense Q3 2025 · Sep 30, 2025 $1.93M
Rd Expense Q3 2025 · Sep 30, 2024 $690K
Rd Expense Q3 2025 · Sep 30, 2024 $2.1M
Operating Income Q3 2025 · Sep 30, 2025 −$7.18M
Operating Income Q3 2025 · Sep 30, 2025 −$10.84M
Operating Income Q3 2025 · Sep 30, 2024 −$1.06M
Operating Income Q3 2025 · Sep 30, 2024 −$2.72M
Gross Profit Q3 2025 · Sep 30, 2025 $372K
Gross Profit Q3 2025 · Sep 30, 2025 $3.28M
Gross Profit Q3 2025 · Sep 30, 2024 $1.72M
Gross Profit Q3 2025 · Sep 30, 2024 $6.1M